Breaking News Instant updates and real-time market news.

2021-03-04 16:07:29 WORK Slack Technologies $39.91 / -0.32 (-0.80%) 16:07 03/04/21 03/04 16:07 03/04/21 16:07	Slack Technologies reports Q4 EPS (1c), consensus (3c) Reports Q4 revenue $250.6M, consensus $239.41M. "This was a tremendous quarter, with leaders and innovators choosing to standardize on Slack in record numbers. We saw accelerating growth in new Paid Customers, adding 14,000 in the most recent quarter, up from 5,000 in the fourth quarter of the prior year, and continued success in the enterprise segment, with Paid Customers with over $1 million in annual recurring revenue up 54% year-over-year. We're continuing to manage the business prudently while investing in our long-term opportunity to help companies make the transformations needed to thrive in the new world of work," said CFO Allen Shim.
WORK Slack Technologies $39.91 / -0.32 (-0.80%) 12/09/20 Morgan Stanley Salesforce $50B revenue target unlikely a source of upside, says Morgan Stanley 12/09/20 Canaccord Salesforce valuation compelling especially on pullback, says Canaccord 12/09/20 Morgan Stanley Slack Technologies upgraded to Equal Weight from Underweight at Morgan Stanley 12/03/20 Wedbush Slack Technologies upgraded to Neutral from Underperform at Wedbush

2021-03-04 16:07:29

WORK

Slack Technologies

$39.91 / -0.32 (-0.80%)

16:07

03/04/21

03/04

16:07

03/04/21

16:07

Slack Technologies reports Q4 EPS (1c), consensus (3c)

Reports Q4 revenue $250.6M, consensus $239.41M. "This was a tremendous quarter, with leaders and innovators choosing to standardize on Slack in record numbers. We saw accelerating growth in new Paid Customers, adding 14,000 in the most recent quarter, up from 5,000 in the fourth quarter of the prior year, and continued success in the enterprise segment, with Paid Customers with over $1 million in annual recurring revenue up 54% year-over-year. We're continuing to manage the business prudently while investing in our long-term opportunity to help companies make the transformations needed to thrive in the new world of work," said CFO Allen Shim.

WORK Slack Technologies

$39.91 / -0.32 (-0.80%)

12/09/20 Morgan Stanley: Salesforce $50B revenue target unlikely a source of upside, says Morgan Stanley

12/09/20 Canaccord: Salesforce valuation compelling especially on pullback, says Canaccord

12/09/20 Morgan Stanley: Slack Technologies upgraded to Equal Weight from Underweight at Morgan Stanley

12/03/20 Wedbush: Slack Technologies upgraded to Neutral from Underperform at Wedbush

TODAY'S FREE FLY STORIES

Options	Preliminary option volume of 32.4M today » 16:30 04/13/21 04/13 16:30 04/13/21 16:30 Preliminary option volume… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Syndicate	Aviat Networks files $200M mixed securities shelf 16:28 04/13/21 04/13 16:28 04/13/21 16:28 AVNW Aviat Networks $34.28 / -3.42 (-9.07%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly AVNW Aviat Networks $34.28 / -3.42 (-9.07%) 03/05/21 Aviat Networks announces two-for-one stock split 02/08/21 Dish selects Aviat Networks for 5G microwave wireless transport 12/02/20 Nextlink Internet selects Aviat Networks for rural broadband AVNW Aviat Networks $34.28 / -3.42 (-9.07%) 02/04/21 Northland Aviat Networks price target raised to $57 from $40 at Northland 08/28/20 Northland Aviat Networks price target raised to $27 from $20 at Northland AVNW Aviat Networks $34.28 / -3.42 (-9.07%) 02/03/21 Aviat Networks reports Q2 non-GAAP EPS $1.48, consensus 72c 11/05/20 Aviat Networks reports Q1 non-GAAP EPS $1.24, consensus 58c AVNW Aviat Networks $34.28 / -3.42 (-9.07%) 02/03/21 Fly Intel: After-Hours Movers
On The Fly	Fly Intel: Wall Street's top stories for Tuesday » 16:27 04/13/21 04/13 16:27 04/13/21 16:27 JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) , MRNA Moderna $149.63 / +10.34 (+7.42%) , COIN Coinbase / + , AGC Altimeter Growth $15.26 / +1.34 (+9.63%) , KURI Alkuri Global Acquisition $10.01 / +0.12 (+1.21%) , BA Boeing $253.15 / +3.49 (+1.40%) , NVCR Novocure $197.33 / +65.72 (+49.94%) , AHCO AdaptHealth $29.89 / -7.16 (-19.33%) , BALY Bally's $54.30 / -6.5 (-10.69%) , JKPTF Gamesys Group $27.00 / + (+0.00%) , ZLAB Zai Lab $161.30 / +29.35 (+22.24%) The major averages had a… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options JNJ MRNA COIN AGC BA NVCR AHCO BALY JKPTF ZLAB JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 09:25 Today Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 07:15 Today J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use MRNA Moderna $149.63 / +10.34 (+7.42%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 09:28 Today Moderna says available mRNA-1273 data doesn't suggest association with CVST 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 04/07/21 Moderna says NEJM study shows COVID antibody persistence out to 6 months COIN Coinbase / + 15:19 Today Coinbase updates on conversion of Class B shares to Class A shares 04/06/21 Crypto Council for Innovation launches with Square,Coinbase, Fidelity as members 03/22/21 Coinbase ordered to pay $6.5M by CFTC for false, misleading reporting 12/17/20 Coinbase announces confidential submission of draft registration statement AGC Altimeter Growth $15.26 / +1.34 (+9.63%) 06:08 Today Grab/Altimeter Growth combo to have equity value of $39.6B on pro-forma basis 06:02 Today Grab Holdings to go public via partnership with Altimeter Growth 03/11/21 Altimeter Growth, Altimeter Growth 2 rally after WSJ report of Grab talks BA Boeing $253.15 / +3.49 (+1.40%) 11:09 Today Boeing reports 196 gross commercial airplane orders in March 11:04 Today Boeing announces 77 commercial airplane deliveries in Q1 04/09/21 Boeing recommends 16 customers address potential issue for some 737 MAX jets 04/08/21 Air Transport Services delivers third Boeing 767 freighter to Raya Airways NVCR Novocure $197.33 / +65.72 (+49.94%) 07:48 Today Zai Lab partner Novocure updates phase 3 Lunar trial in tumor fields in NSCLC 07:40 Today Novocure: DMC recommends continuation of LUNAR trial 12/14/20 Novocure announces BAG to add Optune combination to MiGeL 12/10/20 Novocure enrolls 1st patient in global phase 3 TRIDENT trial AHCO AdaptHealth $29.89 / -7.16 (-19.33%) 09:50 Today AdaptHealth places co-CEO Luke McGee on unpaid leave 09:49 Today AdaptHealth board: Denmark athorities formally charge co-CEO with tax fraud 01/04/21 AdaptHealth falls 5% to $34.00 per share after equity offering 12/01/20 AdaptHealth, AeroCare combination to operate under AdaptHealth name BALY Bally's $54.30 / -6.5 (-10.69%) 12:00 Today Bally's falls -10.3% 10:00 Today Bally's falls -11.5% 09:47 Today Bally's falls -14.5% 07:39 Today Gaming and Leisure Properties to acquire some of Bally's assets for $150M JKPTF Gamesys Group $27.00 / + (+0.00%) 05:26 Today Bally's to combine with Gamesys Group 03/24/21 Bally's reports agreement in principle to buy Gamesys Group plc ZLAB Zai Lab $161.30 / +29.35 (+22.24%) 07:48 Today Zai Lab partner Novocure updates phase 3 Lunar trial in tumor fields in NSCLC 07:40 Today Novocure: DMC recommends continuation of LUNAR trial 03/31/21 Zai Lab, Deciphera announce China NMPA approval of Qinlock NDA 01/11/21 Turning Point Therapeutics, Zai Lab expand collaboration to include TPX-0022 JNJ MRNA COIN AGC KURI BA NVCR AHCO BALY JKPTF ZLAB JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 09:34 Today Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 09:21 Today JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 08:15 Today Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause MRNA Moderna $149.63 / +10.34 (+7.42%) 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 08:15 Today Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study COIN Coinbase / + 09:55 Today Fly Intel: Top five analyst initiations 06:35 Today MoffettNathanson Coinbase initiated with a Buy at MoffettNathanson 04/07/21 JMP Securities Coinbase report shows 'substantial business momentum,' says JMP Securities 03/03/21 Fly Intel: Top five analyst initiations AGC Altimeter Growth $15.26 / +1.34 (+9.63%) KURI Alkuri Global Acquisition $10.01 / +0.12 (+1.21%) BA Boeing $253.15 / +3.49 (+1.40%) 04/09/21 Baird Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets 03/29/21 Goldman Sachs Boeing resuming 787 deliveries removes overhang, says Goldman Sachs 03/19/21 Susquehanna Boeing price target raised to $300 from $250 at Susquehanna 03/15/21 Morgan Stanley Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley NVCR Novocure $197.33 / +65.72 (+49.94%) 12:56 Today Goldman Sachs Zai Lab price target raised to $211.23 after LUNAR trial update at Goldman Sachs 11:34 Today Wells Fargo Novocure price target raised to $215 from $135 at Wells Fargo 10:48 Today Guggenheim Zai Lab price target raised to $250 from $165 at Guggenheim 09:26 Today Piper Sandler DMC review 'clear positive' for Novocure, says Piper Sandler AHCO AdaptHealth $29.89 / -7.16 (-19.33%) 15:00 Today RBC Capital AdaptHealth key leadership remains in place, says RBC Capital 12:14 Today Baird AdaptHealth downgraded to Neutral from Outperform at Baird 11:03 Today Canaccord Charges against McGee not related to AdaptHealth, says Canaccord 10:35 Today Stifel Stifel says AdaptHealth co-CEO news shouldn't have immediate impact on outlook BALY Bally's $54.30 / -6.5 (-10.69%) 04/08/21 KeyBanc Bally's price target raised to $70 from $65 at KeyBanc 03/29/21 Truist Early March casino data looks 'very positive,' says Truist 03/25/21 Stifel Bally's price target raised to $75 from $70 at Stifel 03/24/21 Jefferies Gamesys Group and Bally's an 'interesting combination,' says Jefferies JKPTF Gamesys Group $27.00 / + (+0.00%) 03/24/21 Jefferies Gamesys Group and Bally's an 'interesting combination,' says Jefferies 03/16/21 Jefferies Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies 03/10/21 Berenberg Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg 03/10/21 Deutsche Bank Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank ZLAB Zai Lab $161.30 / +29.35 (+22.24%) 12:56 Today Goldman Sachs Zai Lab price target raised to $211.23 after LUNAR trial update at Goldman Sachs 10:48 Today Guggenheim Zai Lab price target raised to $250 from $165 at Guggenheim 02/08/21 Jefferies Zai Lab price target raised to $225 upon assumption at Jefferies 01/15/21 Citi Citi boosts Zai Lab target to $216, adds to U.S. Focus List JNJ MRNA COIN BA NVCR AHCO BALY ZLAB JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MRNA Moderna $149.63 / +10.34 (+7.42%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) COIN Coinbase / + 04/06/21 Coinbase gives Q2, FY21 expenses guidance 04/06/21 Coinbase reports Q1 estimated total revenue of $1.8B BA Boeing $253.15 / +3.49 (+1.40%) 01/27/21 Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) NVCR Novocure $197.33 / +65.72 (+49.94%) 02/25/21 Novocure reports Q4 EPS 4c, consensus 12c 01/11/21 Novocure sees FY20 revenue $494.4M, consensus $482.29M 01/11/21 Novocure sees Q4 revenue $144M, consensus $133.26M 10/29/20 Novocure reports Q3 EPS 9c, consensus 3c AHCO AdaptHealth $29.89 / -7.16 (-19.33%) 03/04/21 AdaptHealth raises FY21 revenue view to $2.18B-$2.35B from $2.05B-$2.2B 03/04/21 AdaptHealth reports Q4 EPS (47c) with charge, consensus 17c 12/01/20 AdaptHealth raises FY21 revenue view to $2.05B-$2.2B from $1.3B-$1.4B 11/04/20 AdaptHealth sees FY21 revenue $1.3B-$1.4B, consensus $1.21B BALY Bally's $54.30 / -6.5 (-10.69%) 07:03 Today Bally's sees Q1 revenue $185M, consensus $156.45M 03/04/21 Bally's reports Q4 adjusted EPS 39c, consensus (8c) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings ZLAB Zai Lab $161.30 / +29.35 (+22.24%) 03/01/21 Zai Lab reports 2020 EPS ($3.46) vs. ($3.03) last year 16 Apr 14 Apr 06 Jan 15 Dec 03 Sep 01 Jul 19 May JNJ MRNA COIN AGC KURI BA BALY JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 14:59 Today South Africa suspends rollout of Johnson & Johnson vaccine, Bloomberg reports 09:48 Today NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 09:48 Today CVS Health tells Bloomberg pausing administration of J&J COVID vaccine 07:00 Today U.S. to call for pause on J&J vaccine after blood clotting cases, NYT reports MRNA Moderna $149.63 / +10.34 (+7.42%) 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says COIN Coinbase / + 04/06/21 Coinbase's independent directors will have direct ties to company, WSJ reports 03/21/21 Coinbase direct listing pushed back to April, Bloomberg reports 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 12/17/20 Coinbase filed confidentially for IPO, Bloomberg says AGC Altimeter Growth $15.26 / +1.34 (+9.63%) 04/09/21 Grab to announce deal with Altimeter Growth SPAC next week, Bloomberg says 04/09/21 Grab to announce deal with Altimeter Growth SPAC next week, Bloomberg says 04/07/21 Altimeter Growth rallies after FT says deal with Singapore's Grab is close 03/11/21 Singapore's Grab in talks to go public via Altimeter SPAC, WSJ reports KURI Alkuri Global Acquisition $10.01 / +0.12 (+1.21%) 12:48 Today Babylon in talks to go public via Alkuri Global Acquisition, Bloomberg reports BA Boeing $253.15 / +3.49 (+1.40%) 04/09/21 Boeing 737 MAX issue impacts about 90 jets, Reuters reports 04/09/21 Boeing 737 MAX issue impacts about 90 jets, Reuters reports 03/29/21 Boeing urges Delaware court to dismiss investors' 737 MAX lawsuit, Reuters says 03/26/21 Boeing confirms 787 Dreamliner deliveries have resumed, Bloomberg says BALY Bally's $54.30 / -6.5 (-10.69%) 03/10/21 Casino companies prepare to compete for NYC-area license, NY Post reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says JNJ MRNA COIN AGC BA NVCR AHCO BALY JKPTF JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 12:06 Today Fly Intel: Wall Street's top stories at midday 11:12 Today Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 08:58 Today Fly Intel: Pre-market Movers 04/09/21 Fly Intel: Wall Street's top stories for Friday MRNA Moderna $149.63 / +10.34 (+7.42%) 12:06 Today Fly Intel: Wall Street's top stories at midday 11:12 Today Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 08:58 Today Fly Intel: Pre-market Movers 04/06/21 Fly Intel: Wall Street's top stories for Tuesday COIN Coinbase / + 12:06 Today Fly Intel: Wall Street's top stories at midday 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 The Intersection: Crypto and Wall Street This Week 04/03/21 Opening Day: Softbank-backed Compass raises $450M in IPO AGC Altimeter Growth $15.26 / +1.34 (+9.63%) 12:06 Today Fly Intel: Wall Street's top stories at midday 08:58 Today Fly Intel: Pre-market Movers 04/11/21 On the Fly: The Week in SPAC News BA Boeing $253.15 / +3.49 (+1.40%) 12:06 Today Fly Intel: Wall Street's top stories at midday 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Wall Street's top stories for Monday NVCR Novocure $197.33 / +65.72 (+49.94%) 12:06 Today Fly Intel: Wall Street's top stories at midday 08:58 Today Fly Intel: Pre-market Movers AHCO AdaptHealth $29.89 / -7.16 (-19.33%) 12:06 Today Fly Intel: Wall Street's top stories at midday BALY Bally's $54.30 / -6.5 (-10.69%) 12:06 Today Fly Intel: Wall Street's top stories at midday 08:58 Today Fly Intel: Pre-market Movers 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals JKPTF Gamesys Group $27.00 / + (+0.00%) 12:06 Today Fly Intel: Wall Street's top stories at midday 03/24/21 Fly Intel: Wall Street's top stories for Wednesday 03/24/21 Fly Intel: Wall Street's top stories at midday 04/15/21 Aerospace & Defense 05/24/21 Global Healthcare Virtual Conference 2021 04/20/21 Johnson & Johnson - JNJ 04/28/21 Boeing - BA 04/29/21 Novocure - NVCR 05/07/21 Moderna - MRNA 04/14/21 Moderna 04/20/21 Boeing Co. 04/22/21 Johnson & Johnson 04/28/21 Moderna, Inc. 05/18/21 Bally's Corporation JNJ MRNA AGC BA AHCO JNJ Johnson & Johnson $159.51 / -2.075 (-1.28%) 09:40 Today Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th MRNA Moderna $149.63 / +10.34 (+7.42%) 10:25 Today Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish AGC Altimeter Growth $15.26 / +1.34 (+9.63%) 09:40 Today Unusually active option classes on open April 13th 02/24/21 Thirteen new option listings on February 24th BA Boeing $253.15 / +3.49 (+1.40%) 03/29/21 Early notable gainers among liquid option names on March 29th 03/29/21 Unusually active option classes on open March 29th 03/17/21 Call buyers board Boeing as shares gain altitude following 2day slide 03/17/21 Early notable gainers among liquid option names on March 17th AHCO AdaptHealth $29.89 / -7.16 (-19.33%) 11/25/20 new option listings on November 25th
Hot Stocks	Victory Capital reports AUM $154.3B as of March 31st » 16:27 04/13/21 04/13 16:27 04/13/21 16:27 VCTR Victory Capital $27.35 / -0.82 (-2.91%) Victory Capital reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options VCTR Victory Capital $27.35 / -0.82 (-2.91%) 03/10/21 Victory Capital reports AUM $150.6B as of February 28th 03/08/21 Victory Capital announces Alderwood secures FCA authorization 02/10/21 Victory Capital reports AUM of $146.2B as of January 31 01/13/21 Victory Capital reports AUM $147.2B on December 31 VCTR Victory Capital $27.35 / -0.82 (-2.91%) 04/09/21 BofA Victory Capital double-upgraded to Buy from Underperform at BofA 04/09/21 BofA Victory Capital upgraded to Buy from Underperform at BofA 11/19/20 Fly Intel: Top five analyst downgrades 11/19/20 BofA Victory Capital double-downgraded to Underperform from Buy at BofA VCTR Victory Capital $27.35 / -0.82 (-2.91%) 02/10/21 Victory Capital reports Q4 adjusted EPS $1.07, consensus $1.02 11/04/20 Victory Capital reports Q3 adjusted EPS $1.00, consensus 93c 05/13/21 Victory Capital 05/18/21 Victory Capital Holdings, Inc. VCTR Victory Capital $27.35 / -0.82 (-2.91%) 01/06/21 Fifteen new option listings on January 6th
Hot Stocks	Pfizer can deliver 10% more vaccine doses to U.S. by end of May, says CEO » 16:25 04/13/21 04/13 16:25 04/13/21 16:25 PFE Pfizer $37.15 / +0.17 (+0.46%) , BNTX BioNTech $129.64 / +8.13 (+6.69%) Pfizer (PFE) chairman and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE BNTX PFE Pfizer $37.15 / +0.17 (+0.46%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 04/12/21 AgroFresh Solutions appoints Clinton Lewis Jr. as CEO 04/12/21 Myovant Sciences, Pfizer: First patient dosed in Phase 3 SERENE study BNTX BioNTech $129.64 / +8.13 (+6.69%) 04/09/21 Pfizer, BioNTech seek expansion of vaccine EUA to include 12-15 year olds 04/01/21 Pfizer, BioNTech: Vaccine more than 91% effective after 6 months in study 03/31/21 BioNTech, Pfizer: 'Positive' results of COVID-19 vaccine study in adolescents 03/30/21 BioNTech says evaluation of safety of third BNT162b2 dose initiated PFE BNTX PFE Pfizer $37.15 / +0.17 (+0.46%) 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 09:21 Today JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 04/09/21 Pfizer to host conference call 04/06/21 RBC Capital Pfizer transferred with a Sector Perform at RBC Capital BNTX BioNTech $129.64 / +8.13 (+6.69%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley PFE PFE Pfizer $37.15 / +0.17 (+0.46%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open 23 Jul PFE BNTX PFE Pfizer $37.15 / +0.17 (+0.46%) 09:48 Today NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 04/12/21 Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says 04/09/21 EU seeks contract for 1.8B COVID-19 doses with Pfizer, BioNTech, Reuters reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says BNTX BioNTech $129.64 / +8.13 (+6.69%) 04/12/21 Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says 04/09/21 EU seeks contract for 1.8B COVID-19 doses with Pfizer, BioNTech, Reuters reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/05/21 Pfizer working on new deal to supply COVID-19 vaccines to Israel, Reuters says PFE BNTX PFE Pfizer $37.15 / +0.17 (+0.46%) 11:12 Today Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/05/21 Fly Intel: Wall Street's top stories for Monday BNTX BioNTech $129.64 / +8.13 (+6.69%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/01/21 Fly Intel: Wall Street's top stories for Thursday 04/01/21 Fly Intel: Wall Street's top stories at midday 04/15/21 Horizons in Oncology Virtual Conference 05/24/21 Global Healthcare Virtual Conference 2021 05/04/21 Pfizer - PFE 05/10/21 BioNTech - BNTX 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 04/22/21 Pfizer Inc PFE BNTX PFE Pfizer $37.15 / +0.17 (+0.46%) 04/12/21 Unusually active option classes on open April 12th 04/09/21 Pfizer call volume above normal and directionally bullish 04/09/21 Early notable gainers among liquid option names on April 9th 03/15/21 Pfizer call volume above normal and directionally bullish BNTX BioNTech $129.64 / +8.13 (+6.69%) 02/17/21 Largest borrow rate increases among liquid names 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names

Initiation	MAG Silver initiated with a Neutral at CIBC » 16:25 04/13/21 04/13 16:25 04/13/21 16:25 MAG MAG Silver $17.05 / +0.27 (+1.61%) CIBC initiated coverage… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options MAG MAG Silver $17.05 / +0.27 (+1.61%) 10/21/20 MAG Silver announces first production from Juanicipio MAG MAG Silver $17.05 / +0.27 (+1.61%) 02/08/21 Stifel MAG Silver price target raised to C$29 from C$27.75 at Stifel 01/28/21 BMO Capital MAG Silver price target lowered to C$22.50 from C$23.50 at BMO Capital 01/15/21 Raymond James MAG Silver price target raised to C$29 from C$26 at Raymond James 01/11/21 National Bank MAG Silver price target raised to C$35 from C$29.50 at National Bank MAG MAG Silver $17.05 / +0.27 (+1.61%) 03/17/21 Largest borrow rate increases among liquid names 11/13/20 MAG Silver options imply 5.4% move in share price post-earnings 10/14/20 Largest borrow rate increases among liquid names
Initiation	Gatos Silver initiated with an Outperformer at CIBC » 16:23 04/13/21 04/13 16:23 04/13/21 16:23 GATO Gatos Silver $10.19 / +0.49 (+5.05%) CIBC initiated coverage… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events Options GATO Gatos Silver $10.19 / +0.49 (+5.05%) 03/11/21 Gatos Silver commences drilling at Santa Valeria project in Mexico 03/09/21 Gatos Silver increases ownership in LGJV to 70% from 51.5%, extinguishes WCF 02/19/21 Gatos Silver provides update on temporary power restriction at Cerro Los Gatos 02/01/21 Gatos Silver rises 23.9% GATO Gatos Silver $10.19 / +0.49 (+5.05%) 01/29/21 BMO Capital Gatos Silver downgraded to Market Perform from Outperform at BMO Capital 11/24/20 BMO Capital Gatos Silver initiated with an Outperform at BMO Capital 11/23/20 RBC Capital Gatos Silver initiated with an Outperform at RBC Capital 28 Oct GATO Gatos Silver $10.19 / +0.49 (+5.05%) 11/01/20 Opening Day: MediaAlpha jumps 64%, Root falls flat in debut 05/26/21 Gatos Silver Inc GATO Gatos Silver $10.19 / +0.49 (+5.05%) 04/07/21 new option listings and two option delistings on April 7th
Upgrade	Snap upgraded to Outperform upon assumption at Wedbush » 16:21 04/13/21 04/13 16:21 04/13/21 16:21 SNAP Snap $62.44 / + (+0.00%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SNAP Snap $62.44 / + (+0.00%) 03/17/21 Snap acquires Fit Analytics, terms not disclosed 03/03/21 Snap CEO sells 1.54M shares of common stock 02/23/21 Snap sees gross margins continuing to expand in 2021 02/23/21 Snap says Map feature reaches over 250M monthly active users SNAP Snap $62.44 / + (+0.00%) 16:12 Today Wedbush Snap assumed at Outperform from Neutral at Wedbush 04/06/21 Atlantic Equities Snap upgraded to Overweight from Neutral at Atlantic Equities 04/05/21 Evercore ISI Snap assumed with an Outperform at Evercore ISI 03/31/21 Wolfe Research Snap initiated with an Outperform at Wolfe Research SNAP Snap $62.44 / + (+0.00%) 02/04/21 Snap sees Q1 revenue $720M-$740M, consensus $704.57M 02/04/21 Snap reports Q4 adjusted EPS 9c, consensus 7c 02/04/21 Notable companies reporting after market close 10/20/20 Snap says 47%-50% year-over-year revenue growth in Q4 'attainable' SNAP Snap $62.44 / + (+0.00%) 04/06/21 Facebook, Apple and Niantic see a future in augmented -reality glasses, WSJ says 03/30/21 Snap developing new Spectacles with augmented reality, Information reports 03/05/21 Reddit hires Drew Vollero as CFO ahead of eventual IPO, NY Times reports 02/16/21 ByteDance looks to list Douyin in NY as Biden sets new mood, SCMP reports SNAP Snap $62.44 / + (+0.00%) 04/07/21 #SocialStocks: AR glasses seen as future of tech 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 04/06/21 Fly Intel: Pre-market Movers 04/05/21 Roblox jumps as several Wall Street analysts initiate coverage with a Buy 04/22/21 Snap - SNAP SNAP Snap $62.44 / + (+0.00%) 04/12/21 Notable open interest changes for April 12th 04/08/21 Snap Inc. call buyer realizes 13% same-day gains 04/06/21 Unusually active option classes on open April 6th 03/26/21 Notable open interest changes for March 26th
Earnings	Nurix Therapeutics reports Q1 EPS (63c), consensus (46c) » 16:21 04/13/21 04/13 16:21 04/13/21 16:21 NRIX Nurix Therapeutics $26.44 / -0.065 (-0.25%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options NRIX Nurix Therapeutics $26.44 / -0.065 (-0.25%) 03/16/21 Nurix Therapeutics announces collaboration for drugs to treat pediatric cancers 01/07/21 Nurix Therapeutics expands strategic collaboration with Sanofi 10/26/20 Nurix appoints Robert Tjian as chairman of Scientific Advisory Board NRIX Nurix Therapeutics $26.44 / -0.065 (-0.25%) 02/17/21 Piper Sandler Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler 02/16/21 Piper Sandler Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler 01/29/21 JPMorgan Nurix Therapeutics price target raised to $56 from $34 at JPMorgan 11/24/20 Morgan Stanley Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley NRIX Nurix Therapeutics $26.44 / -0.065 (-0.25%) 02/16/21 Nurix Therapeutics reports Q4 EPS (51c), consensus (54c) 10/14/20 Nurix Therapeutics reports Q3 EPS (59c), consensus (41c) 05 Mar 24 Jul 05/24/21 Global Healthcare Virtual Conference 2021 05/06/21 Nurix Therapeutics, Inc. NRIX Nurix Therapeutics $26.44 / -0.065 (-0.25%) 03/17/21 new option listings on March 17th
Hot Stocks	Procter & Gamble raises quarterly dividend 10% to 86.98c per share » 16:21 04/13/21 04/13 16:21 04/13/21 16:21 PG Procter & Gamble $135.12 / -1.78 (-1.30%) The Board of Directors of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PG Procter & Gamble $135.12 / -1.78 (-1.30%) 15:47 Today Procter & Gamble announces multi-year partnership with Major League Soccer 03/28/21 Fly Intel: Top five weekend stock stories 02/12/21 Trian Fund exits nVent, increases stake in GE 01/22/21 Procter & Gamble licenses nasal swab to Rhinostics for Covid test PG Procter & Gamble $135.12 / -1.78 (-1.30%) 03/02/21 BofA Procter & Gamble removed from the US 1 List at BofA 01/28/21 Stifel Stifel downgrades Procter & Gamble to Hold on emerging headwinds 01/28/21 Stifel Procter & Gamble downgraded to Hold from Buy at Stifel 01/19/21 Bernstein Procter & Gamble initiated with a Market Perform at Bernstein PG Procter & Gamble $135.12 / -1.78 (-1.30%) 01/20/21 Procter & Gamble raises FY21 core EPS view to up 8%-10% from up 5%-8% 01/20/21 Procter & Gamble reports Q2 core EPS $1.64, consensus $1.51 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open PG Procter & Gamble $135.12 / -1.78 (-1.30%) 04/09/21 P&G, China trade groups work to avoid Apple's new privacy rules, WSJ reports 03/27/21 Verizon, IBM among stocks to build income stream for long haul, Barron's says 11/13/20 Procter & Gamble new disinfectant on pace for $200M in sales, WSJ reports PG Procter & Gamble $135.12 / -1.78 (-1.30%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/20/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: Pre-market Movers 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 04/20/21 Procter & Gamble - PG PG Procter & Gamble $135.12 / -1.78 (-1.30%) 02/26/21 Unusually active option classes on open February 26th 12/09/20 Notable open interest changes for December 9th 10/20/20 Unusually active option classes on open October 20th

Hot Stocks	ProQR Therapeutics announces journal publication on sepofarsen trial » 16:20 04/13/21 04/13 16:20 04/13/21 16:20 PRQR ProQR Therapeutics $6.01 / +0.05 (+0.84%) ProQR Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly PRQR ProQR Therapeutics $6.01 / +0.05 (+0.84%) 03/25/21 ProQR Therapeutics trading resumes 03/25/21 ProQR Therapeutics trading halted, volatility trading pause 03/24/21 ProQR Therapeutics releases results from clinical trial of QR-421a 01/07/21 ProQR Therapeutics completes enrollment in trial of sepofarsen PRQR ProQR Therapeutics $6.01 / +0.05 (+0.84%) 03/25/21 Citi ProQR Therapeutics price target raised to $44 from $33 at Citi 03/24/21 Cantor Fitzgerald ProQR Therapeutics price target raised to $33 from $22 at Cantor Fitzgerald 03/24/21 JMP Securities ProQR Therapeutics price target raised to $35 from $19 at JMP Securities 11/02/20 Cantor Fitzgerald ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald PRQR ProQR Therapeutics $6.01 / +0.05 (+0.84%) 11/16/20 ProQR Therapeutics reports Q3 EPS (EUR0.26) vs. (EUR0.31) last year 31 Mar PRQR ProQR Therapeutics $6.01 / +0.05 (+0.84%) 03/31/21 Fly Intel: Pre-market Movers
Options	Closing CBOE SPX and VIX Index summary for April 13th » 16:20 04/13/21 04/13 16:20 04/13/21 16:20 VIX Volatility Index S&P 500 Options / + The CBOE Volatility Index… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Options VIX Volatility Index S&P 500 Options / + 09:18 Today Overnight activity included 960 trades in SPX and 47 trades in VIX 04/12/21 Closing CBOE SPX and VIX Index summary for April 12th 04/12/21 Overnight activity included 1154 trades in SPX and 64 trades in VIX 04/09/21 Closing CBOE SPX and VIX Index summary for April 9th
Upgrade	Nihon Kohden upgraded to Overweight from Equal Weight at Morgan Stanley » 16:19 04/13/21 04/13 16:19 04/13/21 16:19 NHNKY Nihon Kohden $14.29 / -0.26 (-1.79%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research NHNKY Nihon Kohden $14.29 / -0.26 (-1.79%) 02/10/21 Daiwa Nihon Kohden downgraded to Neutral from Outperform at Daiwa 01/07/21 Mizuho Nihon Kohden downgraded to Neutral from Buy at Mizuho
Hot Stocks	Shore Bancshares announces new branch in South Ocean City, Maryland » 16:19 04/13/21 04/13 16:19 04/13/21 16:19 SHBI Shore Bancshares $17.00 / -0.04 (-0.23%) Shore Bancshares… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SHBI Shore Bancshares $17.00 / -0.04 (-0.23%) 03/03/21 Shore Bancshares, Severn to merge in roughly $146M deal 11/24/20 Shore Bancshares to repurchase up to $5M of its common stock SHBI Shore Bancshares $17.00 / -0.04 (-0.23%) 03/08/21 Keefe Bruyette Shore Bancshares upgraded to Outperform from Market Perform at Keefe Bruyette SHBI Shore Bancshares $17.00 / -0.04 (-0.23%) 01/28/21 Shore Bancshares reports Q4 cont-op EPS 32c, consensus 23c 10/22/20 Shore Bancshares reports Q3 EPS 27c, consensus 18c 05/12/21 Shore Bancshares, Inc.
Hot Stocks	Results in Endo's phase 3 study show meaningful improvement in severe cellulite » 16:19 04/13/21 04/13 16:19 04/13/21 16:19 ENDP Endo $6.11 / -0.07 (-1.13%) The company states:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ENDP Endo $6.11 / -0.07 (-1.13%) 04/07/21 Endo comments on default liability judgment in Tennessee State court case 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 01/05/21 Endo subsidiary enters into agreement with Radius Health for abaloparatide 01/05/21 Radius Health enters commercial agreement with Paladin Labs for abaloparatide ENDP Endo $6.11 / -0.07 (-1.13%) 04/06/21 RBC Capital Endo transferred with a Sector Perform at RBC Capital 03/08/21 Barclays Endo price target raised to $7 from $6 at Barclays 03/04/21 Citi Endo price target lowered to $10 from $11 at Citi 01/19/21 Citi Endo price target raised to $9 from $7 at Citi ENDP Endo $6.11 / -0.07 (-1.13%) 02/25/21 Endo sees Q1 adjusted EPS 40c-50c, consensus 53c 02/25/21 Endo sees Q1 adjusted EPS 40c-50c, consensus 53c 02/25/21 Endo sees FY21 adjusted EPS $1.80-$2.30, consensus $2.32 02/25/21 Endo reports Q4 adjusted EPS 75c, consensus 48c ENDP Endo $6.11 / -0.07 (-1.13%) 10/21/20 Purdue Pharma to plead guilty in $8B-plus deal, AP reports ENDP Endo $6.11 / -0.07 (-1.13%) 02/25/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: Wall Street's top stories for Monday 10/19/20 Fly Intel: Wall Street's top stories at midday ENDP Endo $6.11 / -0.07 (-1.13%) 12/18/20 Opening seller repeats Endo straddle sale 11/05/20 Endo options imply 66.9% move in share price post-earnings

Hot Stocks	Stitch Fix CEO Lake to transition to executive chairperson role » 16:18 04/13/21 04/13 16:18 04/13/21 16:18 SFIX Stitch Fix $49.46 / -1.3 (-2.56%) Stitch Fix, Inc.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/23/21 Stitch Fix appoints Sharon Chiarella as Chief Product Officer 03/08/21 Stitch Fix says excited about direct buy active client demand 03/08/21 Stitch Fix drops 23% to $52.30 after reporting mixed Q2 results 12/10/20 Stitch Fix CEO: Our success rate was the highest ever during Q1 SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 04/05/21 Evercore ISI Stitch Fix initiated with an Outperform at Evercore ISI 03/09/21 Fly Intel: Top five analyst downgrades 03/09/21 Canaccord Stitch Fix price target lowered to $68 from $72 at Canaccord 03/09/21 KeyBanc Stitch Fix price target lowered to $75 from $95 at KeyBanc SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/08/21 Stitch Fix cuts FY21 revenue view to $2.02B-$2.05B from $2.05B-$2.14B 03/08/21 Stitch Fix sees Q3 revenue $505M-$515M, consensus $522.97M 03/08/21 Stitch Fix reports Q2 EPS (20c), consensus (22c) 03/08/21 Notable companies reporting after market close SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/09/21 Fly Intel: Wall Street's top stories for Tuesday 03/09/21 Fly Intel: Wall Street's top stories at midday 03/09/21 Tesla upgrade, Best Buy initiation among today's top calls on Wall Street 03/09/21 Fly Intel: Pre-market Movers SFIX Stitch Fix $49.46 / -1.3 (-2.56%) 03/08/21 Stitch Fix options imply 27.9% move in share price post-earnings 01/05/21 Stitch Fix put volume heavy and directionally bearish 12/28/20 Stitch Fix put volume heavy and directionally bearish 12/07/20 Stitch Fix options imply 21.3% move in share price post-earnings
Earnings	Flexion sees FY21 revenue $120M-$130M, consensus $137.42M » 16:18 04/13/21 04/13 16:18 04/13/21 16:18 FLXN Flexion $9.37 / +1.05 (+12.62%) FY21 total operating… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate FLXN Flexion $9.37 / +1.05 (+12.62%) 03/31/21 Flexion announces first patient treated in FX201 Phase 1b trial 03/01/21 Flexion announces FDA clearance for FX301 IND application 02/18/21 Flexion to advance FX201 into high dose cohort of Phase 1 trial 02/01/21 NBRPA, Sheryl Swoopes, Flexion partner to raise ZILRETTA awarness FLXN Flexion $9.37 / +1.05 (+12.62%) 04/06/21 RBC Capital Flexion transferred with an Outperform at RBC Capital 08/20/20 Goldman Sachs Flexion initiated with a Neutral at Goldman Sachs 07/30/20 Oppenheimer Flexion initiated with an Outperform at Oppenheimer 07/29/20 Fly Intel: Top five analyst initiations FLXN Flexion $9.37 / +1.05 (+12.62%) 16:17 Today Flexion reports preliminary Q1 revenue $24.6M, consensus $25.23M 01/13/21 Flexion sees 2020 revenue $85.5M, consensus $84.88M 01/13/21 Flexion sees Q4 revenue $26.3M, consensus $25.66M 11/04/20 Flexion reports Q3 EPS (50c), consensus (51c) 21 May
Downgrade	Facebook assumed with Neutral at Wedbush, cites privacy risk » 16:17 04/13/21 04/13 16:17 04/13/21 16:17 FB Facebook $309.74 / -1.96 (-0.63%) , AAPL Apple $134.41 / +3.14 (+2.39%) Wedbush analyst Ygal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 04/09/21 Facebook removes 16,000 groups trading fake reviews, says U.K.'s CMA 04/09/21 Facebook to convert part of Menlo Park HQ into vaccination site 04/08/21 Facebook tweets today's technical glitch was 'quickly resolved' 04/05/21 Facebook announces new ad solution, Dynamic Ads for Streaming AAPL Apple $134.41 / +3.14 (+2.39%) 12:10 Today Apple confirms plans for 'Spring Loaded' event on April 20 06:33 Today Eli Lilly announces Diogo Rau as chief information, digital officer 04/12/21 Apple Mac sales implied up 65% vs. 22% consensus, Gene Munster says 04/02/21 Apple adds over 30 titles to Arcade, bringing total to over 180 games FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 16:09 Today Wedbush Facebook assumed at Neutral from Outperform at Wedbush 04/05/21 Evercore ISI Facebook assumed with an Outperform at Evercore ISI 03/31/21 Wolfe Research Facebook initiated with an Outperform at Wolfe Research 03/29/21 Deutsche Bank Facebook price target raised to $385 from $355 at Deutsche Bank AAPL Apple $134.41 / +3.14 (+2.39%) 04/12/21 Canaccord Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem 04/09/21 Citi Citi tells investors to focus on Apple's capital deployment, iPhone gains 04/08/21 Piper Sandler Teen iPhone ownership continues to increase, says Piper Sandler 04/06/21 Cowen Apple's News product a key growth pillar, says Cowen FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/27/21 Facebook reports Q4 EPS $3.88, consensus $3.22 01/27/21 Notable companies reporting after market close 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 AAPL Apple $134.41 / +3.14 (+2.39%) 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 04/08/21 Facebook experiencing technical problems, Bloomberg reports 04/08/21 Facebook not planning to notify users impacted by data leak, Reuters reports 04/07/21 Facebook didn't hire Black employees because of 'culture fit,' BI reports 04/07/21 Facebook, Google donated to GOP group that pushes voter supression laws, BI says AAPL Apple $134.41 / +3.14 (+2.39%) 05:57 Today Apple's April 20 event prematurely revelead by Siri, MacRumors reports 04/12/21 Apple faces supply constraints with iPad Pros, Bloomberg reports 04/11/21 Apple agrees to testify before Senate on app store concerns, Reuters reports 04/09/21 Apple hires former WarnerMedia executive Jesse Henderson, Information says FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 04/07/21 #SocialStocks: AR glasses seen as future of tech 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/31/21 #SocialStocks: Social media CEOs give congressional testimony yet again AAPL Apple $134.41 / +3.14 (+2.39%) 12:34 Today Game On: GameStop may be looking for new CEO 04/12/21 Tesla, Chipotle upgrades among today's top calls on Wall Street 04/11/21 On the Fly: The Week in SPAC News 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/22/21 Digital Media 04/28/21 Apple - AAPL 04/28/21 Facebook - FB 05/26/21 Facebook Inc. FB AAPL FB Facebook $309.74 / -1.96 (-0.63%) 03/18/21 Facebook call volume above normal and directionally bullish 02/16/21 Facebook call volume above normal and directionally bullish 01/27/21 Facebook options imply 11.6% move in share price post-earnings 01/15/21 Facebook call volume above normal and directionally bullish AAPL Apple $134.41 / +3.14 (+2.39%) 08:55 Today Notable open interest changes for April 13th 04/12/21 Notable open interest changes for April 12th 04/09/21 Notable open interest changes for April 9th 04/09/21 Unusual call flow in option market yesterday
Earnings	Flexion reports preliminary Q1 revenue $24.6M, consensus $25.23M » 16:17 04/13/21 04/13 16:17 04/13/21 16:17 FLXN Flexion $9.37 / +1.05 (+12.62%) As of March 31, the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate FLXN Flexion $9.37 / +1.05 (+12.62%) 03/31/21 Flexion announces first patient treated in FX201 Phase 1b trial 03/01/21 Flexion announces FDA clearance for FX301 IND application 02/18/21 Flexion to advance FX201 into high dose cohort of Phase 1 trial 02/01/21 NBRPA, Sheryl Swoopes, Flexion partner to raise ZILRETTA awarness FLXN Flexion $9.37 / +1.05 (+12.62%) 04/06/21 RBC Capital Flexion transferred with an Outperform at RBC Capital 08/20/20 Goldman Sachs Flexion initiated with a Neutral at Goldman Sachs 07/30/20 Oppenheimer Flexion initiated with an Outperform at Oppenheimer 07/29/20 Fly Intel: Top five analyst initiations FLXN Flexion $9.37 / +1.05 (+12.62%) 01/13/21 Flexion sees 2020 revenue $85.5M, consensus $84.88M 01/13/21 Flexion sees Q4 revenue $26.3M, consensus $25.66M 11/04/20 Flexion reports Q3 EPS (50c), consensus (51c) 21 May
Recommendations	Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners » 16:17 04/13/21 04/13 16:17 04/13/21 16:17 OGI Organigram $2.92 / +0.145 (+5.23%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options OGI Organigram $2.92 / +0.145 (+5.23%) 04/06/21 Organigram acquires The Edibles & Infusions Corporation for C$22M 03/15/21 Organigram CEO looking forward to bring products to U.S. market when time comes 03/11/21 Organigram jumps 36% to $3.95 after investment from British American Tobacco 03/11/21 Organigram, British American Tobacco enter product development collaboration OGI Organigram $2.92 / +0.145 (+5.23%) 04/07/21 BMO Capital Organigram upgraded to Market Perform from Underperform at BMO Capital 03/16/21 Stifel Organigram price target raised to C$6 from C$1.90 at Stifel 03/15/21 BMO Capital Organigram price target raised to C$4 from C$2 at BMO Capital 03/12/21 CIBC Organigram price target raised to C$5 from C$4.25 at CIBC OGI Organigram $2.92 / +0.145 (+5.23%) 11/30/20 Organigram reports Q4 EPS (19.9c) va. (14.4c) last year OGI Organigram $2.92 / +0.145 (+5.23%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says OGI Organigram $2.92 / +0.145 (+5.23%) 04/08/21 Rising High: Canopy Growth to acquire The Supreme Cannabis Company in $435M deal 03/11/21 Fly Intel: Wall Street's top stories for Thursday 03/11/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 08:00 Today Organigram - OGI OGI Organigram $2.92 / +0.145 (+5.23%) 03/11/21 Unusually active option classes on open March 11th 02/22/21 Unusually active option classes on open February 22nd 02/04/21 Unusually active option classes on open February 4th 12/03/20 Largest borrow rate increases among liquid names

Technical Analysis	NASDAQ market internals summary » 16:17 04/13/21 04/13 16:17 04/13/21 16:17 $NSD NASDAQ Market Internals / + Volume was above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 15:17 Today NASDAQ market internals summary 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary
Earnings	PerkinElmer sees Q1 reported revenue growth 98%, consensus $1.19B » 16:16 04/13/21 04/13 16:16 04/13/21 16:16 PKI PerkinElmer $135.39 / +2.695 (+2.03%) PerkinElmer announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PKI PerkinElmer $135.39 / +2.695 (+2.03%) 03/29/21 PerkinElmer's Horizon Discovery announces extention of gene modulation portfolio 03/10/21 Quidel slips, drags on peers as demand for testing 'softens significantly' 03/09/21 PerkinElmer launches comprehensive solutions for detecting SARS-CoV-2 mutations 02/23/21 PerkinElmer launches point of care Covid-19 antigen test for mass screening PKI PerkinElmer $135.39 / +2.695 (+2.03%) 02/03/21 Citi PerkinElmer price target raised to $155 from $150 at Citi 01/07/21 Piper Sandler Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler 01/07/21 Wells Fargo PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo 01/07/21 Wells Fargo PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo PKI PerkinElmer $135.39 / +2.695 (+2.03%) 02/02/21 PerkinElmer sees Q1 adjusted EPS of at least $3.00, consensus $2.40 02/02/21 PerkinElmer sees FY21 adjusted EPS at least $8.50, consensus $8.88 02/02/21 PerkinElmer reports Q4 adjusted EPS $3.96, consensus $3.00 01/11/21 PerkinElmer sees Q4 adjusted EPS 'at least' $3.60, consensus $2.79 PKI PerkinElmer $135.39 / +2.695 (+2.03%) 01/07/21 Fly Intel: Pre-market Movers 04/27/21 PerkinElmer, Inc.
Technical Analysis	NYSE market internals summary » 16:16 04/13/21 04/13 16:16 04/13/21 16:16 $NYE NYSE Market Internals / + Volume was average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 15:16 Today NYSE market internals summary 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary
Initiation	Twitter assumed with a Neutral at Wedbush » 16:14 04/13/21 04/13 16:14 04/13/21 16:14 TWTR Twitter $72.42 / +1.55 (+2.19%) Wedbush analyst Ygal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TWTR Twitter $72.42 / +1.55 (+2.19%) 04/12/21 Twitter building team in Ghana to establish Africa presence 04/08/21 Twitter integrates Nielsen's cross-media solutions into video ad platform 03/23/21 Twitter welcomes Reshuffle team amid API improvements 03/11/21 Super League Gaming to acquire Mobcrush, terms not disclosed TWTR Twitter $72.42 / +1.55 (+2.19%) 04/05/21 Evercore ISI Twitter assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research Twitter initiated with a Peer Perform at Wolfe Research 03/30/21 Morgan Stanley Twitter price target lowered to $68 from $75 at Morgan Stanley 03/29/21 Fly Intel: Top five analyst upgrades TWTR Twitter $72.42 / +1.55 (+2.19%) 02/25/21 Twitter announces three long-term goals, aims to double sales in 2023 02/09/21 Twitter sees Q1 revenue $940M-$1.04B, consensus $965.14M 02/09/21 Twitter reports Q4 adjusted EPS 38c, consensus 31c 02/09/21 Notable companies reporting after market close TWTR Twitter $72.42 / +1.55 (+2.19%) 04/07/21 Twitter has previously discussed $4B acquisition of Clubhouse, Bloomberg reports 04/07/21 Twitter discussed $4B takeover deal for Clubhouse, Bloomberg says 04/07/21 Twitter says eventually users may complete shopping on service, Reuters reports 04/05/21 Justice Thomas suggests utility-like regulation for some tech, CNBC says TWTR Twitter $72.42 / +1.55 (+2.19%) 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 Fly Intel: Wall Street's top stories at midday 04/07/21 #SocialStocks: AR glasses seen as future of tech 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 05/24/21 Global Technology, Media & Communications Virtual Conference 04/29/21 Twitter - TWTR TWTR Twitter $72.42 / +1.55 (+2.19%) 04/08/21 Twitter call volume above normal and directionally bullish 04/07/21 Unusual call flow in option market yesterday 04/06/21 Twitter call volume above normal and directionally bullish 04/06/21 Early notable gainers among liquid option names on April 6th
Hot Stocks	Kura Sushi reports Q2 comparable restaurant sales down 60% » 16:13 04/13/21 04/13 16:13 04/13/21 16:13 KRUS Kura Sushi $31.34 / +0.27 (+0.87%) Adjusted EBITDA was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events KRUS Kura Sushi $31.34 / +0.27 (+0.87%) 04/06/21 Craig-Hallum Kura Sushi price target raised to $40 from $25 at Craig-Hallum 03/04/21 Stephens Kura Sushi price target raised to $42 from $28 at Stephens 03/03/21 BTIG Kura Sushi price target raised to $40 from $22 at BTIG 01/12/21 Craig-Hallum Kura Sushi upgraded to Buy from Hold at Craig-Hallum KRUS Kura Sushi $31.34 / +0.27 (+0.87%) 16:12 Today Kura Sushi reports Q2 adjusted EPS (78c), consensus (78c) 01/11/21 Kura Sushi reports Q1 adjusted EPS (71c), consensus (65c) 11/16/20 Kura Sushi reports Q4 EPS (82c), consensus (58c) 17:00 Today Kura Sushi - KRUS

Events

Earnings calls, analyst events, roadshows and more

XELB
Today at 17:00

Xcel Brands - XELB Conference Calls
KRUS
Today at 17:00

Kura Sushi - KRUS Conference Calls
SEAC
Today at 17:00

SeaChange - SEAC Conference Calls
HPQ
Today at 17:00

HP Inc. Firm Sponsored Meetings
AKYA
Tomorrow at 00:00

Akoya Biosciences - AKYA Syndicate Roadshows

Virtual Meeting
BMEA
Tomorrow at 00:00

Biomea Fusion - BMEA Syndicate Roadshows

Virtual Meeting
BOXL
Tomorrow at 00:00

Boxlight - BOXL Conference Calls
SLS
Tomorrow at 00:00

Sellas Life Sciences - SLS Conference Calls
M ...
Tomorrow at 00:00

7th Annual Virtual Retail Round-Up Conferences

Virtual Event
Tomorrow at 00:00

AACR Virtual Annual Meeting 2021 Conferences

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $ 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Slack Technologies reports Q4 EPS (1c), consensus (3c)

TODAY'S FREE FLY STORIES

Get Full Fly Access